Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopamine and Norepinephrine in Cost-Benefit Decision-Making
NCT06014606Completed
- Sponsor
- Maastricht University
- Start
- Mar 2021
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial comparing Placebo Arm, Haloperidol Arm and Propranolol Arm (3 arms). Primary endpoint: Cost-benefit reinforcement learning performance. Started Mar 2021; status: completed.
02
Drugs
haloperidolpropranolol
Beyond the preview
Go deeper on NCT06014606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06014606.